These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8607397

  • 21. [Paroxysmal supraventricular tachycardia in pregnancy. Value of adenosine and other anti-arrhythmia agents].
    Hösl P, Rust M, Johannigmann J, Schmidt G.
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):313-6. PubMed ID: 8766489
    [Abstract] [Full Text] [Related]

  • 22. [Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias].
    Luciardi H, Berman S, Santana M, Monteros L.
    Arch Inst Cardiol Mex; 1996 Jun; 66(6):505-9. PubMed ID: 9133311
    [Abstract] [Full Text] [Related]

  • 23. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.
    Page RL, Connolly SJ, Wilkinson WE, Marcello SR, Schnell DJ, Pritchett EL, Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators.
    Am Heart J; 2002 Apr; 143(4):643-9. PubMed ID: 11923801
    [Abstract] [Full Text] [Related]

  • 24. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
    Hamer AW, Strathmore N, Vohra JK, Hunt VD.
    Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
    [Abstract] [Full Text] [Related]

  • 25. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 26. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M, Cullen MT, Casadei G.
    Am J Cardiol; 1996 Jan 25; 77(3):60A-75A. PubMed ID: 8607393
    [Abstract] [Full Text] [Related]

  • 27. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
    Wanless RS, Anderson K, Joy M, Joseph SP.
    Am Heart J; 1997 Apr 25; 133(4):441-6. PubMed ID: 9124166
    [Abstract] [Full Text] [Related]

  • 28. Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
    Mary-Rabine L, Telerman M.
    Acta Cardiol; 1988 Apr 25; 43(1):37-48. PubMed ID: 3132008
    [Abstract] [Full Text] [Related]

  • 29. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P, Bernabò D, Faraguti SA.
    Eur Heart J; 2004 Aug 25; 25(15):1310-7. PubMed ID: 15288158
    [Abstract] [Full Text] [Related]

  • 30. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
    Manz M, Lüderitz B.
    Eur Heart J; 1993 Sep 25; 14 Suppl E():91-8. PubMed ID: 8223763
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 32. Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.
    Calvert P, Gupta D.
    Future Cardiol; 2024 Feb 15; 20(3):163-170. PubMed ID: 38717391
    [Abstract] [Full Text] [Related]

  • 33. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing.
    Severson AL, Meyer LT.
    Heart Lung; 1992 Feb 15; 21(4):350-6. PubMed ID: 1629004
    [Abstract] [Full Text] [Related]

  • 34. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
    Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Bhandari AK, Hawkinson RW, Pritchett EL.
    Circulation; 1989 Dec 15; 80(6):1557-70. PubMed ID: 2513143
    [Abstract] [Full Text] [Related]

  • 35. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM, Tulenov MT, Belokopit IN.
    Klin Med (Mosk); 2002 Dec 15; 80(2):57-60. PubMed ID: 11898726
    [Abstract] [Full Text] [Related]

  • 36. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia.
    Byerly WG, Hartmann A, Foster DE, Tannenbaum AK.
    Ann Emerg Med; 1991 May 15; 20(5):552-4. PubMed ID: 2024796
    [Abstract] [Full Text] [Related]

  • 37. Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
    Morady F, Kou WH, Kadish AH, Toivonen LK, Kushner JA, Schmaltz S.
    Circulation; 1989 Apr 15; 79(4):783-90. PubMed ID: 2924411
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 15; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 39. Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.
    Shiraishi H, Ishibashi K, Urao N, Hyogo M, Tsukamoto M, Keira N, Hirasaki S, Seo Y, Shirayama T, Nakagawa M.
    Intern Med; 2002 Jun 15; 41(6):445-8. PubMed ID: 12135176
    [Abstract] [Full Text] [Related]

  • 40. Long term use of flecainide in patients with supraventricular tachycardia.
    Neuss H.
    Drugs; 1985 Jun 15; 29 Suppl 4():21-5. PubMed ID: 4006776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.